Single-center, single-blind, randomized, controlled clinical trial for the treatment of prepuce overlength with new suture device and traditional suture device

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023681

Enrollment

Unknown

Registered

2019-06-07

Start date

2019-06-24

Completion date

Unknown

Last updated

2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

redundant prepuce

Interventions

experimental group:new foreskin suture device

control group:traditional suture device

Eligibility

Sex/Gender

Male

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) foreskin covering all the head of the penis and urethra outside the mouth;(2) the foreskin can be turned up to show the head of the penis;(3)Read and sign the informed consent for surgical treatment.

Exclusion criteria

Exclusion criteria: (1) foreskin and glans deformity; (2) urinary tract infection; (3) foreskin glans inflammation; (4) the foreskin inner plate and the penis head adhesion is serious; (5) combined with coagulation dysfunction and diabetes and other basic diseases that may affect the curative effect of surgery.

Design outcomes

Primary

Measure	Time frame
Degree of postoperative foreskin swelling;	—

Secondary

Measure	Time frame
Pain index;	—

Countries

China

Contacts

Public ContactZhou Tie

Shanghai Changhai Hospital

wenzhoutie80@yahoo.com+86 13918360523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026